Search research articles
Contact Us
Filters
Showing results (71-80 of 79) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 79 results.
Journal of Gastrointestinal Cancer
|
May 25, 2021
A Novel Prognostic Tool in Western and Eastern Biliary Tract Cancer Patients Treated in First-line Setting: the ECSIPOT Index
Giulia Rovesti, Francesco Leone, Giovanni Brandi, et al.
Lung Cancer (Amsterdam, Netherlands)
|
August 13, 2023
Clinical score for colorectal cancer patients with lung-limited metastases undergoing surgical resection: Meta-Lung Score
Pina Ziranu, Paolo Albino Ferrari, Francesco Guerrera, et al.
Journal of Chemotherapy (Florence, Italy)
|
February 14, 2022
Risk-adjusted analysis of survival variability among hospitals treating biliary malignancy
Margherita Rimini, Andrea Casadei-Gardini, Giovanni Brandi, et al.
Journal of Gastrointestinal Cancer
|
February 5, 2021
Prognostic Role of a New Index Tested in European and Korean Advanced Biliary Tract Cancer Patients: the PECS Index
Giulia Rovesti, Francesco Leone, Giovanni Brandi, et al.
Immunotherapy
|
January 20, 2025
Role of Hb to RDW ratio in metastatic renal cell carcinoma patients treated with first-line immunotherapy combinations
Matilde Corianò, Alessandro Lazzarin, Michele Maffezzoli, et al.
The Oncologist
|
December 2, 2025
Homologous recombination repair genetic testing variables and diagnostic paths for prostate cancer patients: a multicenter cohort study
Lorena Incorvaia, Mattia Puglisi, Marco Maruzzo, et al.
Clinical Genitourinary Cancer
|
May 1, 2026
Concomitant medications and survival outcomes in patients receiving avelumab maintenance for advanced urothelial carcinoma: sub analysis of Meet-URO 25 study
Giandomenico Roviello, Martina Catalano, Elisabetta Gambale, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
August 12, 2022
Validation of the easy-to-use lenvatinib prognostic index to predict prognosis in advanced hepatocellular carcinoma patients treated with lenvatinib
Margherita Rimini, Wonseok Kang, Valentina Burgio, et al.
Cancer Immunology, Immunotherapy : CII
|
August 31, 2021
Clinical outcomes of NSCLC patients experiencing early immune-related adverse events to PD-1/PD-L1 checkpoint inhibitors leading to treatment discontinuation
Marco Russano, Alessio Cortellini, Raffaele Giusti, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 79) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 79 results.
Journal of Gastrointestinal Cancer
|
May 25, 2021
A Novel Prognostic Tool in Western and Eastern Biliary Tract Cancer Patients Treated in First-line Setting: the ECSIPOT Index
Giulia Rovesti, Francesco Leone, Giovanni Brandi, et al.
Lung Cancer (Amsterdam, Netherlands)
|
August 13, 2023
Clinical score for colorectal cancer patients with lung-limited metastases undergoing surgical resection: Meta-Lung Score
Pina Ziranu, Paolo Albino Ferrari, Francesco Guerrera, et al.
Journal of Chemotherapy (Florence, Italy)
|
February 14, 2022
Risk-adjusted analysis of survival variability among hospitals treating biliary malignancy
Margherita Rimini, Andrea Casadei-Gardini, Giovanni Brandi, et al.
Journal of Gastrointestinal Cancer
|
February 5, 2021
Prognostic Role of a New Index Tested in European and Korean Advanced Biliary Tract Cancer Patients: the PECS Index
Giulia Rovesti, Francesco Leone, Giovanni Brandi, et al.
Immunotherapy
|
January 20, 2025
Role of Hb to RDW ratio in metastatic renal cell carcinoma patients treated with first-line immunotherapy combinations
Matilde Corianò, Alessandro Lazzarin, Michele Maffezzoli, et al.
The Oncologist
|
December 2, 2025
Homologous recombination repair genetic testing variables and diagnostic paths for prostate cancer patients: a multicenter cohort study
Lorena Incorvaia, Mattia Puglisi, Marco Maruzzo, et al.
Clinical Genitourinary Cancer
|
May 1, 2026
Concomitant medications and survival outcomes in patients receiving avelumab maintenance for advanced urothelial carcinoma: sub analysis of Meet-URO 25 study
Giandomenico Roviello, Martina Catalano, Elisabetta Gambale, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
August 12, 2022
Validation of the easy-to-use lenvatinib prognostic index to predict prognosis in advanced hepatocellular carcinoma patients treated with lenvatinib
Margherita Rimini, Wonseok Kang, Valentina Burgio, et al.
Cancer Immunology, Immunotherapy : CII
|
August 31, 2021
Clinical outcomes of NSCLC patients experiencing early immune-related adverse events to PD-1/PD-L1 checkpoint inhibitors leading to treatment discontinuation
Marco Russano, Alessio Cortellini, Raffaele Giusti, et al.
Page
of 8